NioCorp SVP granted 97,720 stock options
NioCorp Developments Ltd reported that Senior VP Business Development Ernest M. Cleave received a grant of 97,720 employee stock options to buy common shares at an exercise price of $4.74 per share.
Rhea-AI Filing Summary
NioCorp Developments Ltd reported that Senior VP Business Development Ernest M. Cleave received a grant of 97,720 employee stock options to buy common shares at an exercise price of $4.74 per share. According to the vesting schedule, 34% vested on the grant date, 33% will vest on the first anniversary, and the remaining balance will vest on July 6, 2028. These options expire on July 6, 2031 and represent compensation rather than an open-market stock purchase or sale.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 97,720 shares
Grant/Award
1 txn
Insider
Cleave Ernest M.
Role
Senior VP Business Development
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (Right to Buy) | 97,720 | $0.00 | $0.00 |
Holdings After Transaction:
Employee Stock Option (Right to Buy) — 97,720 contracts (Direct)
Footnotes (1)
- F1. 34% of the options vested on the grant date, 33% of the options will vest on the first anniversary of the grant date, and the remaining balance will vest on the second anniversary of the grant date (July 6, 2028).
Key Figures
Options granted: 97,720 options
Exercise price: $4.74 per share
Immediate vesting portion: 34% of options
+5 more
8 metrics
Options granted
97,720 options
Employee stock option grant to Senior VP Business Development
Exercise price
$4.74 per share
Option strike price for NioCorp common shares
Immediate vesting portion
34% of options
Vested on the grant date
First anniversary vesting
33% of options
Vests on first anniversary of grant date
Final vesting date
July 6, 2028
Remaining balance of options vest
Option expiration
July 6, 2031
Expiration date of employee stock options
Shares underlying options
97,720 common shares
Underlying security for the employee stock options
Post-grant derivative holdings
97,720 options
Total derivative securities following the transaction
Key Terms
Employee Stock Option (Right to Buy), grant date, vest, exercise price, +1 more
5 terms
Employee Stock Option (Right to Buy) financial
"security_title: Employee Stock Option (Right to Buy)"
grant date financial
"34% of the options vested on the grant date"
The grant date is the day a company formally gives an employee or contractor the right to receive stock-based compensation, such as stock options or restricted shares. It matters to investors because it fixes key terms—like the price, the start of the ownership clock, and when the award will affect the company’s financial statements and share count—so it can influence dilution, reported expenses, and potential future selling pressure.
vest financial
"33% of the options will vest on the first anniversary"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
exercise price financial
"conversion_or_exercise_price: 4.7400"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2031-07-06T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did NioCorp Developments (NB) report for Ernest M. Cleave?
NioCorp reported that Senior VP Business Development Ernest M. Cleave received a grant of 97,720 employee stock options. These options give him the right to buy common shares at a fixed exercise price as part of his compensation package.
How many stock options did Ernest M. Cleave receive from NioCorp Developments (NB)?
Ernest M. Cleave received 97,720 employee stock options. Each option allows him to purchase one common share at the specified exercise price, subject to the vesting schedule outlined in the grant’s terms and conditions.
What is the exercise price of Ernest M. Cleave’s NioCorp (NB) stock options?
The exercise price of Ernest M. Cleave’s employee stock options is $4.74 per share. This is the fixed price he must pay to buy each common share once the related options have vested and before they expire.
How do the NioCorp (NB) stock options granted to Ernest M. Cleave vest?
The options vest in three stages: 34% vested on the grant date, 33% vest on the first anniversary of the grant, and the remaining balance vests on the second anniversary, which is July 6, 2028, if service-based conditions are met.
When do Ernest M. Cleave’s NioCorp (NB) stock options expire?
Ernest M. Cleave’s employee stock options expire on July 6, 2031. He must exercise any vested options before this expiration date; otherwise, any unexercised options will lapse and no longer be exercisable.
Is Ernest M. Cleave’s NioCorp (NB) Form 4 transaction a market purchase or sale?
No, the Form 4 reflects a grant of employee stock options, not a market purchase or sale of existing shares. It represents compensation issued by NioCorp, giving him future rights to buy shares at a set price.
AI-generated analysis. How Rhea-AI works. Not financial advice.
